Teva Pharmaceutical (TEV) Revenue

36 Followers

Teva Pharmaceutical Revenue

Teva Pharmaceutical had a revenue of 4.14B in the quarter ending Jun 30, 2026, with 4.04%. This bring the company's revenue in the last twelve months to 17.31B, Increased -0.20%. In the fiscal year ending Dec 31, 2025, Teva Pharmaceutical had annual revenue of 17.26B with 4.31% growth.

Revenue (ttm)

17.31B

Revenue Growth

-2.63%

P/S Ratio

2.12

Revenue/Employee

€539,146

Employees

32,008

Market Cap

€36.52B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	17.26B	713.00M	+4.31%
Dec 31, 2024	16.54B	699.00M	+4.41%
Dec 31, 2023	15.85B	920.00M	+6.16%
Dec 31, 2022	14.93B	-953.00M	-6.00%
Dec 31, 2021	15.88B	-781.00M	-4.69%
Dec 31, 2020	16.66B	-228.00M	-1.35%
Dec 31, 2019	16.89B	-1.97B	-10.43%
Dec 31, 2018	18.85B	-3.53B	-15.77%
Dec 31, 2017	22.39B	―	―